Ireland· IE-PA-EU/1/14/959/002-003
Lynparza 100 mg Film-coated tablet
A olaparib product containing olaparib, registered in Ireland by AstraZeneca AB. The same ATC class is registered in 2 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Olaparib is registered in 2 of 19 countries.
Countries holding a registration under ATC L01XX46 (olaparib), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 1 of them publish a price we can compare per daily dose
Olaparib · ATC L01XX46
2 / 19 countries
- Belgiumprice
- Ireland
The record
At a glance
HPRA (Ireland)- Active substance
- Olaparib
- Manufacturer
- AstraZeneca AB
- Country
- Ireland (IE)
- ATC code
- L01XX46
- ATC class
- Olaparib
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/14/959/002-003
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
507 interactions on record for olaparib.
Graded by severity as the source publishes them — 104 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Olaparib · interactions on record
507 records
- 104 severe
- 400 moderate
- 3 minor
Most severe, free to view
- AprepitantA04AD12severe
- LonafarnibA16AX20severe
- BerotralstatB06AC06severe
- DronedaroneC01BD07severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Olaparib in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainLYNPARZA 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULAAstrazeneca Ab
- FinlandLynparzaAstraZeneca AB
- SwitzerlandLynparza 100 mg, FilmtablettenAstraZeneca AG
- CzechiaLYNPARZAAstraZeneca AB, Södertälje
- United StatesLynparzaAstraZeneca Pharmaceuticals LP
- PolandLynparzaAstraZeneca AB
- SwedenLynparza 100 mg Filmdragerad tablettAstraZeneca AB
- IcelandLynparzaAstraZeneca AB
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Lynparza
- Liechtenstein · Lynparza
- Norway · Lynparza
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ab9f6870-dbb9-4233-b7a1-8c3c77686e52 GET /v1/drugs/ab9f6870-dbb9-4233-b7a1-8c3c77686e52?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"L01XX",
"L01XX46"
],
"strength": null,
"pa_number": "EU/1/14/959/002-003",
"substances": [
"Olaparib"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "08/05/2018",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about olaparib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.